Zofran Birth Defect Cases Being Accepted by Weitz and Luxenberg

| From
Photo: consumer protection law

NEW YORK, N.Y., April 7, 2015 (SEND2PRESS NEWSWIRE) -- Weitz & Luxenberg, P.C., announced it is accepting cases of congenital heart defects and cleft facial abnormalities in children whose mothers took the prescription drug Zofran during pregnancy to relieve symptoms of morning sickness.

Zofran - generic name ondansetron - has never been approved by the U.S. Food & Drug Administration (FDA) for treatment of morning sickness symptoms and medical studies have linked Zofran use during the first trimester of pregnancy to birth defects, the law firm said.

Weitz & Luxenberg added that approximately 1 million women take Zofran or ondansetron each year to relieve the symptoms of morning sickness, specifically nausea and vomiting.

Zofran is FDA-approved for use by cancer patients to prevent the nausea and/or vomiting that can accompany chemotherapy and that can occur after an operation, the firm explained.

However, Zofran has not been approved by the FDA to prevent or treat morning sickness in pregnant women.

Zofran Maker Accused by U.S. Justice Dept.:

In 2012, the manufacturer of Zofran - pharmaceutical giant GlaxoSmithKline - paid a fine of $1 billion as part of a settlement of claims brought by the U.S. Department of Justice, Weitz & Luxenberg said.

The Justice Department claimed, among other things, that GlaxoSmithKline illegally promoted certain forms of Zofran for the treatment of morning sickness in pregnant women, and paid doctors to promote and prescribe Zofran, the firm indicated.

Despite that settlement, GlaxoSmithKline still faces civil liability. Weitz & Luxenberg said it is moving forward with efforts to hold GlaxoSmithKline accountable by accepting cases where women who took Zofran in the first trimester of pregnancy gave birth to children with congenital heart defects and/or cleft lip, cleft palate or both.

Free Consultation For Zofran Birth Defect Victims:

The law firm said Zofran victims can contact Weitz & Luxenberg for a no-cost, no-obligation discussion of their legal rights to compensation from Zofran's maker.

The free consultation can be arranged by contacting Weitz & Luxenberg toll-free at 844-400-HELP or online at, the firm said.

In addition to wanting to hear from mothers who took Zofran, Weitz & Luxenberg also expressed interest in exploring the legal rights of men and women born with a potentially Zofran-related birth defect who this year are between the ages of 18 and 24.

About Weitz & Luxenberg:
Weitz & Luxenberg P.C. is among the nation's leading and most readily recognized personal injury and consumer protection law firms. Weitz & Luxenberg's numerous litigation areas include: mesothelioma, defective medicine and devices, environmental pollutants, products liability, consumer protection, accidents, personal injury, and medical malpractice. Victims of consumer fraud are invited to rely on Weitz & Luxenberg's more than 25 years of experience handling such cases. You can contact the firm's Client Relations department at 800-476-6070 or at

More information:

Twitter: @WeitzLuxenberg

News Source:
For more information regarding this press release, please visit:
Like, Share, Save this press release:
  TWEET   SHARE   G+   PIN IT   STUMBLE   LinkedIn   Instapaper   Buffer

Shortlink to this press release:
The content of the above press release was provided by the “news source” (Weitz and Luxenberg P.C.) or authorized agency, who is solely responsible for its accuracy. Send2Press® is the originating wire service for this story and content is Copr. © 2015 Weitz and Luxenberg P.C. with newswire version Copr. © 2015 Send2Press (a service of Neotrope). All trademarks acknowledged.

Rights granted for reproduction by any legitimate news organization. However, if news is cloned/scraped verbatim, then original attribution must be maintained with link back to this page as “original syndication source.” Resale of this content for commercial purposes is prohibited without a license. Reproduction on any site selling a competitive service is also prohibited. Information is believed accurate, as provided by news source or authorized agency, however is not guaranteed, and you assume all risk for use of any information found herein/hereupon. This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License.
STORY READS for this single page only, as of Oct 25 2016:
[ count retired 8.4.16 ]

back to top
REFERENCES: consumer protection law, Zofran, GlaxoSmithKline, ondansetron, first trimester of pregnancy, birth defects, news, press release from Weitz and Luxenberg P.C., Apr 7, 2015, Drugs and Pharmaceuticals, Health, Family, New York, New York, Zofran Birth Defect Cases Being Accepted by Weitz and Luxenberg